Asia-Pacific Interventional Cardiology Devices Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)

Interventional cardiology is a minimally invasive procedure which involves catheters to treat or diagnose the CAD (Coronary Artery Disease). CAD is the most common type of heart diseases which are occurring. Interventional cardiology devices are medical devices which are introduced to treat the heart diseases. Catheter performs the whole procedure by using fluoroscopy. Interventional cardiology provides the fast recovery, short hospital stay, reduces the complications, and controls the bleeding.  The most common type of interventional cardiology technique is PTCA (percutaneous transluminal coronary angioplasty) is used for the management of coronary atherosclerosis.

Asia Pacific Interventional Cardiology Devices Market Size & Growth:

The Asia Pacific interventional cardiology devices market is envisaged to reach USD XX Billion by 2024 from USD XX Billion in 2018, at a CAGR close to XX% during the forecast period. The key factors leading the interventional cardiology devices market are growing geriatric population, increasing prevalence of CAD, and technological advancements in interventional cardiology devices. The interventional cardiology market size is growing rapidly in emerging economies due to the technological advancements in cardiology. Stringent regulatory approvals and reimbursement issues are restraining the market growth during the forecast period. The advent of bioresorbable stents is creating opportunities for the interventional cardiology and peripheral vascular devices market which are more profitable. According to the reports by WHO (World Health Organization), the total death of people caused by CAD are nearly 11.5 Million. Also, the rising demands for the minimally invasive surgeries are leading the market growth during the forecast period.

Asia Pacific Interventional Cardiology Devices Market Segments Share:

By considering the segmentation, the interventional cardiology devices market is categorised by product type, end-users, and geography. By product type, the market is classified into stents, catheters, interventional cardiology systems, PTCA (Percutaneous Transluminal Coronary Angioplasty), PTCA balloons, and others. Stents have taken up the majority interventional cardiology devices market share. Stents are again segmented into bare metal stents, drug-eluting, and bioresorbable stents. Among these, drug-eluting stents are holding the greater demand, owing to the higher efficiency of treatment, and reduces the in-stent restenosis. By geography, the market is segmented into the Asia Pacific, North America, Europe, South America, and the Middle East and Africa. Asia Pacific region is likely to show a significant growth due to healthcare infrastructure, and rising prevalence of heart-related diseases. Introduction of minimally interventional cardiology procedures coupled with the rising adoption rate of medical tourism is also contributing to the market in Asia Pacific region.

Asia Pacific Interventional Cardiology Devices Market Trends:

• Cordis Corporation, a leading top player in interventional cardiology devices market, released MOZEC Rx PTCA Balloon Dilatation Catheter which indicates the stenotic portion of a coronary artery to improve the myocardial perfusion.
• Cordis Corporation introduces NIRxcell Stent System to improve coronary luminal diameter in patients.

Asia Pacific Interventional Cardiology Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major key players in the Asia Pacific Interventional Cardiology Devices Market are:

• Abbott Laboratories
• Terumo Corporation
• Johnson & Johnson
• Boston Scientific Corporation
• Medtronic Inc.
• Cordis Corporation
• Biosensors International Ltd

Along with these companies, there were many other companies considered/ cited in the report while analysing the Asia Pacific interventional cardiology devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.